OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
21 hedge funds and large institutions have $2.41M invested in OncoSec Medical Incorporated in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
11% less capital invested
Capital invested by funds: $2.71M → $2.41M (-$295K)
19% less funds holding
Funds holding: 26 → 21 (-5)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$191K |
| 2 |
BlackRock
New York
|
+$70.7K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$48.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35.5K |
| 5 |
Millennium Management
New York
|
+$19.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$280K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$262K |
| 3 |
Renaissance Technologies
New York
|
-$117K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$18K |
ONCS Hedge Fund Activity: Q1 2017 in Review
21 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2017, worth a combined $2.41M — down 11% from $2.71M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ONCS and 5 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $191K. The largest seller was Anson Funds Management, exiting entirely with an estimated $280K sold.
- 21 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2017, down from 26 in Q4 2016.
- Funds reported $2.41M of OncoSec Medical Incorporated stock for Q1 2017, down 11% quarter-over-quarter.
- 5 funds opened new OncoSec Medical Incorporated positions in Q1 2017 and 7 closed out, a net change of -2 holders.
- The largest OncoSec Medical Incorporated buyer in Q1 2017 was Vanguard Group, an estimated $191K added.
- The largest OncoSec Medical Incorporated seller in Q1 2017 was Anson Funds Management, an estimated $280K sold.
Based on aggregated 13F filings for Q1 2017.